Dr. Xiangqian Zheng 郑向前
Chief Physician, Associate Professor
Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Thyroid cancer radical surgery, functional neck lymph node dissection, and diagnosis, treatment, and comprehensive management of head and neck tumors.
Dr. Zheng earned a Master of Surgery from Nankai University in 2007 and a PhD in Oncology from Tianjin Medical University in 2013. From 2011 to 2013, Dr. Zheng studied at Moffitt Cancer Center and MD Anderson Cancer Center in the US, obtaining a PhD from Moffitt Cancer Center.
Professional roles
- Member, Chinese Medical Association
- Standing Committee Member and Secretary-General, Thyroid Cancer Professional Committee, China Anti-Cancer Association
- Standing Committee Member and Secretary-General, Head and Neck Tumor Professional Committee, China Anti-Cancer Association
- Vice Chair, Head and Neck Tumor Professional Committee, China Medicine Education Association
Name order: in Chinese the family name comes first (Zheng Xiangqian). Papers usually list the name as Xiangqian Zheng or Zheng X.
Selected publications
144 papers on PubMed matched by name and affiliation; 31 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Endocrinol (Lausanne), 2026 (senior author): A nomogram as a predictive tool for lymph node metastasis in papillary thyroid carcinoma. PubMed 42381872
- Int J Biol Sci, 2026 (senior author): PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling. PubMed 42157931
- Transl Pediatr, 2026 (senior author): Risk factors for postoperative recurrence of thyroid cancer patients in children, adolescents, and young adults. PubMed 41982945
- Endocrine, 2025 (senior author): Multi-omics analysis unveils dysregulation of the tumor immune microenvironment and development of a machine learning-based multi-gene classifier for predicting lateral lymph node metastasis in papillary thyroid carcinoma. PubMed 40517210
- Cancer Gene Ther, 2025 (senior author): Enhancer hijacking drives FAM20C expression to promote papillary thyroid cancer progression. PubMed 40588505
- Biol Proced Online, 2025 (senior author): Comprehensive Insights into APOBEC Mutations in Thyroid Cancer: Prognostic and Therapeutic Discoveries. PubMed 40713522
- Cell Death Dis, 2025 (senior author): The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma. PubMed 40593465
- Thyroid, 2025 (senior author): Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population. PubMed 40441683
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion